APOE genotype effects on Alzheimer's disease onset and epidemiology
about
Alzheimer's disease as homeostatic responses to age-related myelin breakdownMetabolic dysfunction in Alzheimer's disease and related neurodegenerative disordersThe roles of lipid and glucose metabolism in modulation of β-amyloid, tau, and neurodegeneration in the pathogenesis of Alzheimer diseaseiTRAQ analysis of complex proteome alterations in 3xTgAD Alzheimer's mice: understanding the interface between physiology and diseasePeripheral delivery of a CNS targeted, metalo-protease reduces aβ toxicity in a mouse model of Alzheimer's diseaseIs ApoE ɛ 4 a good biomarker for amyloid pathology in late onset Alzheimer's disease?Additional mechanisms conferring genetic susceptibility to Alzheimer's diseaseAlzheimer's disease and environmental exposure to lead: the epidemiologic evidence and potential role of epigeneticsGenetic determinants of human health span and life span: progress and new opportunitiesThe apolipoprotein E (APOE) gene appears functionally monomorphic in chimpanzees (Pan troglodytes)Possible modification of Alzheimer's disease by statins in midlife: interactions with genetic and non-genetic risk factorsAPOE genotype and neuroimaging markers of Alzheimer's disease: systematic review and meta-analysis.Multiple kernel learning with random effects for predicting longitudinal outcomes and data integration.Long-term neprilysin gene transfer is associated with reduced levels of intracellular Abeta and behavioral improvement in APP transgenic miceLow plasma leptin in cognitively impaired ADNI subjects: gender differences and diagnostic and therapeutic potential.A neuroprotective brain-penetrating endopeptidase fusion protein ameliorates Alzheimer disease pathology and restores neurogenesis.Molecular mechanisms of neurodegeneration in Alzheimer's disease.Effect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer diseaseImpact of gene patents and licensing practices on access to genetic testing for Alzheimer disease.Using genetics to enable studies on the prevention of Alzheimer's diseaseDesigning prevention programmes to reduce incidence of dementia: prospective cohort study of modifiable risk factors.Genetic connections between neurological disorders and cholesterol metabolismAntioxidant therapy in Alzheimer's disease: theory and practice.The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE.Complex and multidimensional lipid raft alterations in a murine model of Alzheimer's diseaseCDK5 activator protein p25 preferentially binds and activates GSK3βAlzheimer's disease: new therapies and the role of biomarkers.Brain aging and dementia during the transition from late adulthood to old age: design and methodology of the "Invece.Ab" population-based study.Effects of apoE deficiency and occlusal disharmony on amyloid-beta production and spatial memory in ratsApolipoprotein E genotype is associated with temporal and hippocampal atrophy rates in healthy elderly adults: a tensor-based morphometry studyActivation of estrogen receptor alpha increases and estrogen receptor beta decreases apolipoprotein E expression in hippocampus in vitro and in vivo.Repositioning leptin as a therapy for Alzheimer's diseaseFeelings of Hopelessness in Midlife and Cognitive Health in Later Life: A Prospective Population-Based Cohort Study.F-spondin gene transfer improves memory performance and reduces amyloid-β levels in mice.Meta-analysis of association between the genetic polymorphisms on chromosome 11q and Alzheimer's disease susceptibility.Dementia--epidemiological considerations, nomenclature, and a tacit consensus definition.Genome-wide haplotype association study identify TNFRSF1A, CASP7, LRP1B, CDH1 and TG genes associated with Alzheimer's disease in Caribbean Hispanic individualsMutation-based structural modification and dynamics study of amyloid beta peptide (1-42): An in-silico-based analysis to cognize the mechanism of aggregation.Genome-wide DNA methylation differences between late-onset Alzheimer's disease and cognitively normal controls in human frontal cortex.Age and apoE associations with complex pathologic features in Alzheimer's disease.
P2860
Q22251261-A6D1E7FD-DB25-4F90-943A-AB8C1DDCD286Q24562763-03F2AB1F-925D-4913-AD8F-A6CEDA776C9BQ26777969-58E5400E-CC4F-4FDA-8B2C-E3C6E4AC1E17Q27300851-C9CA0E40-B857-4D01-9D7C-7BB4FD5CCC5AQ27437619-0C4950DF-F079-4AFF-AA69-66938339B890Q28069073-6CB3A190-3138-42FB-8536-369C1FF991BBQ28391511-058ACFD2-930C-45E7-83F3-A3EDC84BFB9AQ28394199-B64178F9-CE23-4090-90CF-AAAC18BC4466Q28469271-E6375AD2-7216-421B-939E-5A836EAA7E98Q28714850-D15D997F-5BD9-4AE2-BF4D-00C19F25216EQ30814231-AA756023-F826-40B4-9D0C-68BBA5970B5DQ30823419-F508940F-D855-4079-8240-260F805244E3Q30980714-3A23C06D-CE6B-4CBD-87C7-0F10562451A3Q33384861-60BDE49E-49A7-40E9-A3D5-9992C8DD3944Q33692408-BE129B83-23F6-4052-AC66-BB9D413AF18EQ33793059-E3098CF0-15E0-4670-ADB9-EA6805E8ED15Q33871297-459873EA-8EBE-47D8-9668-43365B25014AQ33917722-8B6859FD-3F59-4D6C-83D6-C2A29C4F8F89Q34032455-C7830754-80A3-415B-8AD8-901EECD254EAQ34038890-6BD47C79-9A49-4790-AEF0-46DBD99DC551Q34047968-B0C64CE7-BB50-4397-BC3C-2F76823B1D21Q34053056-F464204B-BE87-461C-B11B-1C382E789AF1Q34066474-DB50923D-E063-4924-999B-FF022728EBA4Q34123651-AE5F1BD6-2693-4DDB-8177-20BA507FFAEEQ34381556-E3B16BBE-8047-4015-9573-D34428331D7CQ34525891-AB9EE43C-B3E5-401E-BD19-94827E64C901Q34906741-45E31454-7C4F-4B00-8561-DCB1B5CBC0A0Q34996345-10285BF3-C80A-4803-8655-7EF2D6A80393Q34997429-3CEBD18C-8E26-4366-A8B0-88AC4740BF24Q35021802-CFF4505A-C6AC-4621-8378-512120DA7103Q35130848-8209003E-883F-44E6-9269-CD1873959AEAQ35569809-6251393A-15F1-4ABB-BA1A-BD09F5E34019Q35804604-7C2B3933-7683-432C-9D6A-CBB0AED25296Q36317638-BAB20E29-BDA8-4568-9857-D13D43A8A2D7Q36411784-15DBC145-A80D-4CF8-9EFB-9A43089BD77BQ36552884-776DABE1-36DB-4B57-AC4C-CD1066B0B70BQ36618909-95E46E24-0C90-48AE-9D7F-C9870C2F986EQ36652734-9EA58845-BE7E-49D9-AE97-03C279924878Q36838757-D51CBAA5-4744-4E4E-9828-2629B5E67A4CQ36942274-38A668AD-CF88-4159-A6E0-14EF2D7A3259
P2860
APOE genotype effects on Alzheimer's disease onset and epidemiology
description
2004 nî lūn-bûn
@nan
2004 թուականին հրատարակուած գիտական յօդուած
@hyw
2004 թվականին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
APOE genotype effects on Alzheimer's disease onset and epidemiology
@ast
APOE genotype effects on Alzheimer's disease onset and epidemiology
@en
APOE genotype effects on Alzheimer's disease onset and epidemiology
@nl
type
label
APOE genotype effects on Alzheimer's disease onset and epidemiology
@ast
APOE genotype effects on Alzheimer's disease onset and epidemiology
@en
APOE genotype effects on Alzheimer's disease onset and epidemiology
@nl
prefLabel
APOE genotype effects on Alzheimer's disease onset and epidemiology
@ast
APOE genotype effects on Alzheimer's disease onset and epidemiology
@en
APOE genotype effects on Alzheimer's disease onset and epidemiology
@nl
P356
P1476
APOE genotype effects on Alzheimer's disease onset and epidemiology
@en
P2093
J Wesson Ashford
P2888
P304
P356
10.1385/JMN:23:3:157
P407
P577
2004-01-01T00:00:00Z
P6179
1024552351